Business
Israel’s Clal Biotechnology Industries has sold the exclusive worldwide commercialization rights for its cancer treatment pidilizumab to the American company Medivation. The rights are...
Hi, what are you looking for?
Jewish Business News
All posts tagged "Biotech"
Business
– Clal Biotechnology and Hyperion have agreed on an independent assessment of Andromeda’s Type 1 diabetes treatment. – Clal Biotechnology (TASE: CBI), managed...
Court
Clal Biotechnology Industries Ltd. (TASE: CBI announced yesterday that it had filed a $200 million suit against drug company Hyperion Therapeutics Inc. (Nasdaq: HPTX)...
World News
Clal Biotechnology Industries Ltd. (TASE: CBI) notified the Tel Aviv Stock Exchange this morning that it had contacted Hyperion Therapeutics Inc. (Nasdaq: HPTX) as...
Business
– Investor Mori Arkin: If Hyperion overlooked weak points in the data, it’s their mistake. – The Andromeda affair, in which an Israeli company...
Blogs
– Wound closure technology saves Israeli soldiers. Soldiers wounded in Operation Protective Edge are benefiting from a brand-new Israeli technology to close open wounds quickly. TopClosure...
Money
Fed Chief Janet Yellen is concerned that the flight to high-risk assets and junk bonds could lead to a financial bubble.
StartUps
– Executives in Israel for the MIXiii conference tell “Globes” about the future of medicine. – – 2014 is positioned to go down...
Business
– – 2013 was a positive year for Israeli high-tech and biotech, in almost every respect: total investments rose, salaries rose, and there were...
VC, Investments
– Deloitte’s EMEA Fast 500 ranks three Israeli companies, myThings, Trusteer and among the ten European technology companies with the highest rates of growth. myThings, which...